3219.0000 28.70 (0.90%)
NSE Aug 11, 2025 15:31 PM
Volume: 51,648
 

3219.00
0.90%
Karvy
Strong Position in North India, Expanding in South and West Regions: Dr. Lal Path Labs is the second largest diagnostic chain in domestic market with healthy balance sheet and strong cash flows. The company gets 72% of revenue from North India, and is concentrating more on an engagement model between thecompany and the clients. The future acquisitions and partnerships would provide operating synergies and basis for organic growth in these new regions.
Dr. Lal Pathlabs Ltd. is trading above all available SMAs
More from Dr. Lal Pathlabs Ltd.
Recommended